According to a recent press release from the European parliament, an EU-wide action plan is requested with ambitious and achievable objectives for phasing-out…

When you can see the world clearly, it’s easy to get where you want to go: You might still get where…

On June 7, 2021, the FDA approved aducanumab, an amyloid beta-directed monoclonal antibody indicated for the treatment of Alzheimer’s disease.However, most…

Many publications leave it to readers to guess whether reported data are based on independent biological replicates (e.g. number of animals)…

by Plinio Cabrera Casarotto, PhD,Editor-in-Chief JRepNeurosci The replicability of results is a cornerstone of science. We can only rely on the outcomes…

Communicating science is difficult. We were told to tell exciting stories around our scientific discoveries – and it is certainly true…

In one of the recent Nature issues, there was a piece called “France’s reforms: the costs of competitiveness”. In a nutshell,…

Since the seminal paper by Laura Bohn 20 years ago, expectations have built up that biased mu-opioid receptor agonists will deliver what we…

We have written repeatedly (LINK, LINK) about the border between the fields of Good Research Practice and Research Integrity being more nuanced…

In a recent case before the US District Court in the District of Nevada, the judge ruled six method-of-use patents to…